| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/22/2004 | EP1458759A2 Human antibodies against human glycoprotein vi and their use |
| 09/22/2004 | EP1458758A2 Adiponectin fragments and conjugates |
| 09/22/2004 | EP1458756A1 Chemokine mutants acting as chemokine antagonists |
| 09/22/2004 | EP1458755A2 Novel g-protein coupled receptors and dna sequences thereof |
| 09/22/2004 | EP1458754A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 09/22/2004 | EP1458753A1 Modified bacterial surface layer proteins |
| 09/22/2004 | EP1458752A2 Polypeptides of pseudomonas aeruginosa |
| 09/22/2004 | EP1458738A2 Thermus oshimai nucleic acid polymerases |
| 09/22/2004 | EP1458737A2 Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin |
| 09/22/2004 | EP1458428A1 Method for improving functionality of tissue constructs |
| 09/22/2004 | EP1458411A2 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 09/22/2004 | EP1458403A2 Compositions and methods for the treatment and clinical remission of psoriasis |
| 09/22/2004 | EP1458373A1 Use of lipoxin analogs to promote cell defense against gram-negative infections |
| 09/22/2004 | EP1458241A2 Modified antigen-presenting cells |
| 09/22/2004 | EP1458240A2 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 09/22/2004 | EP1458234A1 Disruption of the prostaglandin e synthase 2 gene |
| 09/22/2004 | EP1409713A4 ASSAY FOR MEASURING FACTOR VIIa-ANTITHROMBIN COMPLEXES |
| 09/22/2004 | EP1259598B1 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 09/22/2004 | EP1218396B1 Antibodies specific for fullerenes |
| 09/22/2004 | EP1147122A4 Methods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants |
| 09/22/2004 | EP1045704B1 Methods for quenching pathogen inactivators in biological materials |
| 09/22/2004 | EP1007691B1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
| 09/22/2004 | EP1005539B1 Ikk-alpha proteins, nucleic acids and methods |
| 09/22/2004 | EP0915970B1 Type c lectins |
| 09/22/2004 | EP0910624B1 Process for producing and multiplying lymphocytes |
| 09/22/2004 | EP0894866B1 Tec tyrosine kinase promoter |
| 09/22/2004 | EP0742822B1 Folding proteins |
| 09/22/2004 | EP0726914B1 Cell surface protein expressed on human cortical thymocyte and their use |
| 09/22/2004 | EP0706575B1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives |
| 09/22/2004 | EP0636179B1 Oil-body proteins as carriers of high-value peptides in plants |
| 09/22/2004 | CN1531653A Method for identification of proteins from intracellular bacteria |
| 09/22/2004 | CN1531600A New polynucleotides and polypeptides of IFN 2-21 gene |
| 09/22/2004 | CN1531596A Methods for stable transduction of cells with viral vectors |
| 09/22/2004 | CN1531594A Novel glyphosate N-acetyltransferase (GAT) genes |
| 09/22/2004 | CN1531592A Process for preparation of neutrophil inhibitory factor |
| 09/22/2004 | CN1531591A Method for introducing nucleic acids and other biologially active molecules into nucleus of higher exkaryotic cells by means of electrical current |
| 09/22/2004 | CN1531590A Aspergillus ocharceus 11 alpha hydroxylase and oxidoreductase |
| 09/22/2004 | CN1531589A Disposable vessel |
| 09/22/2004 | CN1531553A WT1 modified peptide |
| 09/22/2004 | CN1531440A Pharmaceutical composition for preventing or treating TH1 and TH2 cell related diseases by modulating TH/TH2 ratio |
| 09/22/2004 | CN1530440A Monocolone antibody, encoding gene, its uses and hybrid nodule cell line for cecreting same |
| 09/22/2004 | CN1530439A Hair weeds bacterial culture and culturing product |
| 09/22/2004 | CN1167793C Polypeptides encoded by human lipase-like gene, compositions and methods |
| 09/21/2004 | US6794560 Cloning and expression of gai gene of arabidopsis thaliana and homologues from other species, and use of the genes in plants; manipulation of expression of gai and gai genes in plants results in tall or dwarfed plants |
| 09/21/2004 | US6794558 Nucleic acid module coding for αglucosidase, plants that synthesize modified starch, methods for the production and use of said plants, and modified starch |
| 09/21/2004 | US6794500 RNA-binding protein |
| 09/21/2004 | US6794498 Method of eliminating inhibitory/instability regions of mRNA |
| 09/21/2004 | US6794182 Hyperbaric oxygen organ preservation system (HOOPS) |
| 09/21/2004 | US6794178 Nucleotide sequences coding transport protein for us in the treatment and diagnosis of cancer, arthritis, vision defects and skin dsorders |
| 09/21/2004 | US6794174 Full-length infectious cDNA clones of tick borne flavivirus |
| 09/21/2004 | US6794170 Nucleic acid fragment and vector comprising a halogenase, and a process for halogenating chemical compounds |
| 09/21/2004 | US6794169 Enzymatic polypeptide for use in the biosynthesis of glycans |
| 09/21/2004 | US6794168 Using monooxygenase enzyme p450cam; may be carried out in cells, animals or plants; for reducing environmental pollution |
| 09/21/2004 | US6794166 Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands |
| 09/21/2004 | US6794163 Methods to culture circovirus |
| 09/21/2004 | US6794154 Comprises assaying a test substance for the activity of up-regulating the expression of liver-type fatty acid-binding protein (l-fabp) in animal cells; peroxisome proliferator-activated receptor agonists; |
| 09/21/2004 | US6794149 GABA B receptors |
| 09/21/2004 | US6794145 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 09/21/2004 | US6793939 Tissue graft composition comprising liver basement membrane; graft composition can be implanted to replace or induce repair of damaged or diseased tissues |
| 09/21/2004 | US6793933 Dietary supplements for enhancing the immune system |
| 09/21/2004 | US6793924 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated t cells and thereby inhibits t cell activation of b cells |
| 09/21/2004 | US6793920 Antithrombotic agent and anti-von willebrand factor monoclonal antibody |
| 09/21/2004 | US6793675 Polysaccharide sponges for cell culture and transplantation |
| 09/21/2004 | CA2156181C Method for obtaining an increased production of a producing celline by using a fusion protocol |
| 09/16/2004 | WO2004078985A1 Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 09/16/2004 | WO2004078984A1 Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 09/16/2004 | WO2004078980A1 Nucleic acid and method of examining canceration using the nucleic acid |
| 09/16/2004 | WO2004078964A1 Method of producing hybridoma and utilization thereof |
| 09/16/2004 | WO2004078961A1 Floatation support and method of floatation/recovery |
| 09/16/2004 | WO2004078957A1 DENDRITIC CELL PRESENTING α-GLYCOSYLCERAMIDE DERIVATIVE AND ANTIGEN AND USABLE IN SUPPRESSING IMMUNE RESPONSE |
| 09/16/2004 | WO2004078956A2 Process for detaching confluent cells from two dimensional microsupports and its application for preparing transplants |
| 09/16/2004 | WO2004078955A1 Animal-free cell culture method |
| 09/16/2004 | WO2004078954A1 Biodegradable dual porous scaffold wrapped with semi-permeable membrane and tissue cell culture using thereof |
| 09/16/2004 | WO2004078944A2 Thrombin, soluble jaggedi, and trap and growth of stem cells |
| 09/16/2004 | WO2004078938A2 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 09/16/2004 | WO2004078928A2 T cell regulation |
| 09/16/2004 | WO2004078927A2 Progenitor cells and methods of using same |
| 09/16/2004 | WO2004078917A2 Expansion of renewable stem cell populations using modulators of pi 3-kinase |
| 09/16/2004 | WO2004078916A2 In vitro micro-organs, and uses related thereto |
| 09/16/2004 | WO2004078915A2 Cell culture |
| 09/16/2004 | WO2004078909A2 Identification of antigen epitopes |
| 09/16/2004 | WO2004078782A1 Methods for increasing the proliferation of b cells |
| 09/16/2004 | WO2004078777A2 Dipeptidyl-peptidase protected proteins |
| 09/16/2004 | WO2004078776A2 Ny-eso-1 peptides which bind to class ii molecules and uses thereof |
| 09/16/2004 | WO2004078195A1 Agent for converting intestinal cell into insulin-producing cell and remedy for diabetes |
| 09/16/2004 | WO2004078140A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF |
| 09/16/2004 | WO2004078130A2 Posh interacting proteins and related methods |
| 09/16/2004 | WO2004078022A2 Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues |
| 09/16/2004 | WO2004067697A3 Icos+ suppresser t cells |
| 09/16/2004 | WO2004067696A3 Interspecies embryonic stem cells |
| 09/16/2004 | WO2004062592A3 2-o sulfatase compositions and related methods |
| 09/16/2004 | WO2004050706A3 Regulatory t-cells |
| 09/16/2004 | WO2004050679A3 Mutant glycoproteins |
| 09/16/2004 | WO2004047731A8 Modulation of notch3 expression |
| 09/16/2004 | WO2004020606A3 Method of resisting osteoclast formation |
| 09/16/2004 | WO2003106658A3 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter |
| 09/16/2004 | WO2003099999A3 Generation and selection of protein library in silico |
| 09/16/2004 | WO2003089603A3 Cytokine receptor |
| 09/16/2004 | WO2003085099B1 A process for the preparation of stem cells from human muscle tissue and adipose tissue, and stem cells obtainable by this process |
| 09/16/2004 | WO2003052048A3 Nucleic acid-associated proteins |